S. Sugiyama et al. / Tetrahedron: Asymmetry 24 (2013) 1069–1074
1073
gel column chromatography (CHCl3/MeOH, 9:1) to afford allylgly-
cine derivative 7a (194 mg, 88%). Other amino acid derivatives
7c, d, f and their enantiomers ent-7c, d, f were also synthesized
on a 1.00 mmol scale. For the syntheses of ent-7c, d, and f, (S)-
tert-butanesulfinamide (S)-4 was used instead of (R)-tert-butane-
sulfinamide (R)-4.
125 MHz) d: 174.0 (C@O), 140.3 (C@CH2), 114.6 (C@CH2), 57.5
(NCH), 57.0 (C), 42.5 (CH2), 23.0 (Me ꢀ 3), 22.0 (Me). IR (KBr) cmꢁ1
:
3248 (s), 1717 (s), 1266 (s), 1017 (s). HRMS (positive FAB) m/z:
234.1163 (M+1)+ (Calcd for C10H20NO3S: 234.1165).
4.2.7. (2S,SS)-2-(tert-Butylsulfinamido)-4-methylpent-4-enoic
acid ent-7f
½
a 3D0
ꢂ
¼ þ32:2 (c 1.0, CHCl3). 1H NMR spectra were identical to
4.2.1. (2R,RS)-2-(tert-Butylsulfinamido)pent-4-enoic acid 7a
those of 7f. HRMS (positive FAB) m/z: 234.1163 (M+1)+ (Calcd for
Pale yellow oil. ½a D23
ꢂ
¼ ꢁ32:6 (c 1.0, CHCl3). 1H NMR (500 MHz,
C10H20NO3S: 234.1165).
CDCl3) d: 5.70–5.78 (1H, m, H2C@CH), 5.13 (1H, d, J = 7.9 Hz,
HHC@CH), 5.10 (1H, s, HHC@CH), 4.45 (1H, d, J = 7.6 Hz, NH, D2O
exchangeable), 3.98 (1H, dd, J = 12.8, 7.3 Hz, NCH), 2.72–2.57 (1H,
m, CHH), 2.44–2.49 (1H, m, CHH), 1.24 (9H, s, tBu). 13C NMR (CDCl3,
125 MHz) d: 174.1 (C@O), 132.9 (CH@CH2), 119.1 (CH@CH2), 58.5
(NCH), 57.0 (C), 38.5 (CH2), 23.0 (Me ꢀ 3). IR (film) cmꢁ1: 3274
(s), 2976 (s), 1734 (s), 1475 (s), 1372 (s), 1150 (s), 1011 (s). HRMS
(positive FAB) m/z: 220.1002 (M+1)+ (Calcd for C9H18NO3S:
220.1008).
4.3. General procedure to remove the tert-butylsulfinyl group
(Table 3)
A mixture of 7a (41.5 mg, 0.189 mmol) in aq HCl (6 mol/L,
1.9 mL) was stirred for 4 h at 90 °C. After the reaction mixture
was concentrated in vacuo, the residue was purified over DOWEX
50 W ꢀ 4 (100–200 mesh, H+ activated, 0.80 g). Next, H2O followed
by 2.8% NH3 aq eluted 10a (15.0 mg, 69%). For the synthesis of 10d,
ent-10d, 11, and ent-11, the ion exchanged materials of them were
chromatographed on silica gel (neutral) (CHCl3/MeOH/28% NH3 aq,
70:30:2).
4.2.2. (2R,3S,RS)-2-(tert-Butylsulfinamido)-3-methylpent-4-
enoic acid 7c
Yellowish crystalline material, mp 127–129 °C. ½a D24
¼ ꢁ78:5 (c
ꢂ
1.0, CHCl3). 1H NMR (500 MHz, CDCl3) d: 5.73–5.80 (1H, m,
CH@CH2), 5.09 (1H, dd, J = 4.9, 0.9 Hz, CH@CHH), 5.06 (1H, d,
J = 0.9 Hz, CH@CHH), 4.40 (1H, d, J = 8.2 Hz, NH), 3.88 (1H, dd,
4.3.1. (R)-2-Aminopent-4-enoic acid 10a
Colorless powder, mp 149 °C (dec). ½a D25
¼ þ23:7 (c 0.11, H2O)
ꢂ
J = 8.2, 3.4 Hz, NCH), 2.61–2.68 (1H, m, MeCH), 1.29 (9H, s, Bu),
for 94% ee {Ref., ½a D22
ꢂ
¼ þ33:8 (c 1.05, H2O) for 95% ee29}. 1H
t
1.03 (3H, d, J = 7.0 Hz, Me). 13C NMR (CDCl3, 125 MHz) d: 172.9
(C@O), 139.3 (CH@CH2), 116.0 (CH@CH2), 62.9 (NCH), 57.1 (C),
41.5 (CH), 22.9 (Me ꢀ 3), 14.5 (Me). IR (KBr) cmꢁ1: 3268 (s), 2979
(s), 1721 (s), 1459 (m), 1384 (m), 1254 (m), 1024 (s). HRMS (posi-
tive FAB) m/z: 234.1160 (M+1)+ (Calcd for C10H20NO3S: 234.1165).
NMR (500 MHz, D2O) d: 5.75–5.83 (1H, m, CH@CH2), 5.29 (1H, d,
J = 17.1 Hz, CH@CHH), 5.27 (1H, d, J = 10.1 Hz, CH@CHH), 3.82
(1H, dd, J = 6.7, 5.2 Hz, NCH), 2.67 (1H, m, CHH), 2.63 (1H, m,
CHH). 13C NMR (D2O, 125 MHz) d: 177.0 (C@O), 134.2 (CH@CH2),
123.3 (CH@CH2), 56.8 (NCH), 37.7 (CH2). NMR data were good
agreement with those of the reported data.29 IR (KBr) cmꢁ1: 2928
(s), 1578 (s). HRMS (positive FAB) m/z: 116.0709 (M+1)+ (Calcd
for C5H10NO2: 116.0712). HPLC: tS = 5.5 min and tR = 7.0 min.
(RS)-Allylglycine (Aldrich) was used as a (RS)-sample. 10a:ent-
10a = 97:3 (94% ee).
4.2.3. (2S,3R,SS)-2-(tert-Butylsulfinamido)-3-methylpent-4-
enoic acid ent-7c
½
a 3D0
ꢂ
¼ þ74:1 (c 1.0, CHCl3). 1H NMR spectra were identical to
those of 7c. HRMS (positive FAB) m/z: 234.1166 (M+1)+ (Calcd for
C10H20NO3S: 234.1165).
4.3.2. (2R,3S)-2-Amino-3-methylpent-4-enoic acid 10c
Product 10c (31.9 mg, 82%) was obtained from 7c (70.0 mg,)
according to the procedure described in Section 4.3.1. Colorless
4.2.4. (2R,3S,RS)-2-(tert-Butylsulfinamido)-3-propylpent-4-
enoic acid 7d
Pale yellow oil. ½a D29
ꢂ
¼ ꢁ37:9 (c 1.0, CHCl3). 1H NMR (500 MHz,
powder, mp 205 °C (dec). ½a D26
¼ ꢁ15:8 (c 0.61, H2O) {Ref., for
ꢂ
CDCl3) d: 5.60 (1H, dt, J = 17.1, 9.8 Hz, CH@CH2), 5.11 (1H, d,
J = 10.7 Hz, CH@CHH), 5.08 (1H, d, J = 17.4 Hz, CH@CHH), 4.36
(1H, d, J = 8.5 Hz, NH), 3.86 (1H, dd, J = 8.5, 5.2 Hz, CH), 2.37–2.43
(1H, m, NCH), 1.44–1.50 (1H, m, CHH), 1.20–1.49 (3H, m, CHH
(2S,3R)-isomer, ½a D24
ꢂ
¼ þ16:0 (c 1.02, H2O)16}. 1H NMR (500 MHz,
D2O) d: 5.86 (1H, ddd, J = 17.7, 10.5, 6.3 Hz, CH@CH2), 5.27 (1H,
d, J = 11.0 Hz, CH@CHH), 5.26 (1H, d, J = 16.8 Hz, CH@CHH), 3.78
(1H, d, J = 4.0 Hz, MeCH), 2.86–2.93 (1H, m, NCH), 1.11 (3H, d,
J = 7.0 Hz, Me). 13C NMR (D2O, 125 MHz) d: 174.0 (C@O), 138.3
(CH@CH2), 118.2 (CH@CH2), 59.1 (NCH), 38.4 (CH), 13.8 (Me).
NMR data were good agreement with those of the reported data.25
IR (KBr) cmꢁ1: 2944 (m), 1583 (s), 1508 (s), 1412 (m). HRMS
(positive FAB) m/z: 130.0866 (M+1)+ (Calcd for C6H12NO2:
130.0869). HPLC: t2S = 8.6 min and t2R = 10.9 min. 10c:ent-
10c = >99:1 (>98% ee).
and CH2), 1.29 (9H, s, Bu). 13C NMR (CDCl3, 125 MHz) d: 172.8
t
(C@O), 137.6 (CH@CH2), 117.8 (CH@CH2), 62.7 (NCH), 57.0 (C),
48.1 (CH), 31.8 (CH2), 22.9 (Me ꢀ 3), 20.1, (CH2), 13.9 (Me). IR
(CHCl3) cmꢁ1: 2956 (s), 1729 (s), 1456 (m), 1368 (m), 1039 (m).
HRMS (positive FAB) m/z: 262.1482 (M+1)+ (Calcd for C12H24NO3S:
262.1478).
4.2.5. (2S,3R,SS)-2-(tert-Butylsulfinamido)-3-propylpent-4-enoic
acid ent-7d
Useful characteristic NMR signals to distinguish 10c from the
corresponding anti-amino acid are as follows;25 1H NMR (D2O),
syn 3.76 ppm (d, J = 4.1 Hz) and anti 3.61 ppm (d, J = 5.5 Hz). 13C
NMR (D2O), syn 13.6 ppm and anti 16.0 ppm.
½
a 2D9
ꢂ
¼ þ37:8 (c 1.3, CHCl3). 1H NMR spectra were identical to
those of 7d. HRMS (positive FAB) m/z: 262.1482 (M+1)+ (Calcd
for C12H24NO3S: 262.1478).
4.3.3. (2S,3R)-2-Amino-3-methylpent-4-enoic acid ent-10c
Product ent-10c (32.7 mg, 84%) was obtained from ent-7c
(70.0 mg) according to the procedure described in Section 4.3.1.
4.2.6. (2R,RS)-2-(tert-Butylsulfinamido)-4-methylpent-4-enoic
acid 7f
Pale yellow solid, mp 113–118 °C. ½a D28
ꢂ
¼ ꢁ33:9 (c 1.1, CHCl3).
Mp 208 °C (dec). ½a D26
ꢂ
¼ þ16:9 (c 0.61, H2O) {Ref.16
½
a 2D4
ꢂ
¼ þ16:0
1H NMR (500 MHz, CDCl3) d: 4.84 (1H, s, C@CHH), 4.77 (1H, s,
C@CHH), 4.41 (1H, d, J = 8.5 Hz, NH), 4.03 (1H, dt, J = 8.9, 5.2 Hz,
NCH), 2.53 (1H, dd, J = 14.0, 5.2 Hz, CHH), 2.33 (1H, dd, J = 14.0,
(c 1.02, H2O)}. 1H NMR spectra were identical to those of 10c.
HRMS (positive FAB) m/z: 130.0872 (M+1)+ (Calcd for C6H12NO2:
130.0869). HPLC: t2S = 8.6 min and t2R = 10.9 min. ent-10c:10c =
>99:1 (>98% ee).
9.2 Hz, CHH), 1.74 (3H, s, Me), 1.26 (9H, s, Bu). 13C NMR (CDCl3,
t